Literature DB >> 9524061

Thyropins--new structurally related proteinase inhibitors.

B Lenarcic1, T Bevec.   

Abstract

Thyroglobulin type-1 domain is a structural element found in a variety of functionally unrelated proteins. It may occur singly, as in insulin-like growth factor binding proteins, or multiply up to eleven, as in thyroglobulin. Some of these type-1 domain containing proteins have been shown to have the ability to inhibit either cysteine or cation-dependent proteinases. For these inhibitory proteins we proposed the term thyropins. These inhibitors originate from a variety of organisms and presumably have different biological functions. One of those whose function has been studied is the p41 invariant chain fragment. In vivo it associates with the major histocompatibility complex (MHC) class II molecule. The evidence supporting its involvement as a controlling factor in the process of antigen presentation is described.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9524061

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  31 in total

1.  A human protein containing multiple types of protease-inhibitory modules.

Authors:  M Trexler; L Bányai; L Patthy
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

2.  Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S.

Authors:  G Guncar; G Pungercic; I Klemencic; V Turk; D Turk
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

Review 3.  Lysosomal cysteine proteases: facts and opportunities.

Authors:  V Turk; B Turk; D Turk
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

4.  Characterization of SMOC-2, a modular extracellular calcium-binding protein.

Authors:  Christian Vannahme; Silke Gösling; Mats Paulsson; Patrik Maurer; Ursula Hartmann
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

5.  Sequence conservation in the chagasin family suggests a common trend in cysteine proteinase binding by unrelated protein inhibitors.

Authors:  Daniel J Rigden; Vladimir V Mosolov; Michael Y Galperin
Journal:  Protein Sci       Date:  2002-08       Impact factor: 6.725

6.  Inhibitory p41 isoform of invariant chain and its potential target enzymes cathepsins L and H in distinct populations of macrophages in human lymph nodes.

Authors:  Valentina Zavasnik-Bergant; Ana Schweiger; Tadeja Bevec; Rastko Golouh; Vito Turk; Janko Kos
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

7.  Crystallization and preliminary X-ray crystallographic analysis of the cysteine protease inhibitor clitocypin.

Authors:  Katja Galesa; Joze Brzin; Jerica Sabotic; Dusan Turk
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-12-16

Review 8.  Lysosomal enzymes, cathepsins in brain tumour invasion.

Authors:  Natasa Levicar; Tadej Strojnik; Janko Kos; Ricardo A Dewey; Geoffrey J Pilkington; Tamara T Lah
Journal:  J Neurooncol       Date:  2002-05       Impact factor: 4.130

Review 9.  Cysteine cathepsins in neurological disorders.

Authors:  Anja Pišlar; Janko Kos
Journal:  Mol Neurobiol       Date:  2013-11-15       Impact factor: 5.590

Review 10.  Thyroglobulin From Molecular and Cellular Biology to Clinical Endocrinology.

Authors:  Bruno Di Jeso; Peter Arvan
Journal:  Endocr Rev       Date:  2015-11-23       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.